Ritholtz Wealth Management Kamada LTD Transaction History

Ritholtz Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$6.02 - $8.06 $107,342 - $143,717	-17,831 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$6.3 - $8.46 $103,603 - $139,124	-16,445 Reduced 47.98%	17,831 $116,000
Q3 2020 Oct 23, 2020	BUY	$8.02 - $11.73 $40,412 - $59,107	5,039 Added 17.24%	34,276 $287,000
Q2 2020 Jul 15, 2020	BUY	$5.37 - $9.45 $93,239 - $164,080	17,363 Added 146.23%	29,237 $227,000
Q1 2020 Apr 09, 2020	BUY	$4.56 - $7.13 $54,145 - $84,661	11,874 New	11,874 $69,000

6.37M

2.2K

63.8K

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $235M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Ritholtz Wealth Management with notifications on news.